Ladu, Sara

Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma

Tschaharganeh, D. F., Chen, X., Latzko, P., Malz, M., Gaida, M. M., Felix, K., Ladu, S., Singer, S., Pinna, F., Gretz, N., et al. (2013) · Gastroenterology

Hippo pathway signaling and YAP/TAZCancer-related molecular mechanisms research

Cited by 326

Disruption of β-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice

Calvisi, D. F., Factor, V. M., Ladu, S., Conner, E. A., & Thorgeirsson, S. S. (2004) · Gastroenterology

Wnt/β-catenin signaling in development and cancerHepatocellular Carcinoma Treatment and Prognosis

Cited by 100

Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53

Calvisi, D. F., Simile, M. M., Ladu, S., Frau, M., Evert, M., Tomasi, M. L., Demartis, M. I., Daino, L., Seddaiu, M. A., Brozzetti, S., et al. (2011) · Hepatology

Cancer-related Molecular PathwaysHepatocellular Carcinoma Treatment and Prognosis

Cited by 65

Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype

Frau, M., Ladu, S., Calvisi, D. F., Simile, M. M., Bonelli, P., Daino, L., Tomasi, M. L., Seddaiu, M. A., Feo, F., & Pascale, R. M. (2011) · Journal of Hepatology

Clusterin in disease pathologyHepatocellular Carcinoma Treatment and Prognosis

Cited by 60